Publications

Journal Article Epublish 35 citations
Electronic publication date
May 1, 2021

View on Pubmed.gov 33928245 | View on doi.org 10.1093/brainco...

Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.

Search for publications in this journal Brain Commun - 3(2):fcab028

Abstract

Plaques that characterize Alzheimer's disease accumulate over 20 years as a result of decreased clearance of amyloid-β peptides. Such long-lived peptides are subjected to multiple post-translational modifications, in particular isomerization. Using liquid chromatography ion mobility separations mass spectrometry, we characterized the most common isomerized amyloid-β peptides present in the temporal cortex of sporadic Alzheimer's disease brains. Quantitative assessment of amyloid-β N-terminus revealed that > 80% of aspartates (Asp-1 and Asp-7) in the N-terminus was isomerized, making isomerization the most dominant post-translational modification of amyloid-β in Alzheimer's disease brain. Total amyloid-β was ∼85% isomerized at Asp-1 and/or Asp-7 residues, with only 15% unmodified amyloid-β left in Alzheimer's disease. While amyloid-β the next most abundant N-terminus found in Alzheimer's disease brain, was only ∼50% isomerized at Asp-7 in Alzheimer's disease. Further investigations into different biochemically defined amyloid-β-pools indicated a distinct pattern of accumulation of extensively isomerized amyloid-β in the insoluble fibrillar plaque and membrane-associated pools, while the extent of isomerization was lower in peripheral membrane/vesicular and soluble pools. This pattern correlated with the accumulation of aggregation-prone amyloid-β in Alzheimer's disease brains. Isomerization significantly alters the structure of the amyloid-β peptide, which not only has implications for its degradation, but also for oligomer assembly, and the binding of therapeutic antibodies that directly target the N-terminus, where these modifications are located.

References

Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16742-7

Anal Chem. 2016 Aug 2;88(15):7548-55

Neuron. 2011 Sep 8;71(5):833-44

Neurology. 2019 Oct 22;93(17):e1647-e1659

Cited by 35 citations (total)

Journal Article Research Support, N.I.H., Extramural

Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging.

Electronic publication date October 23, 2023

Search for publications in this journal ACS Chem Neurosci

Brooke Holcombe [...] Ayanjeet Ghosh et al.

Aggregation of amyloid β (Aβ) peptides into extracellular plaques is a hallmark of the molecular pathology of Alzheimer's disease (AD)....

Journal Article Review

Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer's Disease.

Electronic publication date January 12, 2024

Search for publications in this journal Int J Mol Sci

Sergey A Kozin [...] Vladimir A Mitkevich et al.

A hallmark of Alzheimer's disease (AD) are the proteinaceous aggregates formed by the amyloid-beta peptide (Aβ) that is deposited inside...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Copyright

© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.